These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7747876)

  • 1. [Susceptibility of LDL to lipid peroxidation in non-insulin-dependent diabetes mellitus with or without macroangiopathy].
    Gallou G; Ruelland A; Campion L; Allannic H; Legras B; Cloarec L
    Ann Biol Clin (Paris); 1994; 52(10):695-9. PubMed ID: 7747876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid profile and its relation to fasting insulin level in non-insulin dependent diabetes mellitus (NIDDM).
    Uddin F; Miah AK
    Bangladesh Med Res Counc Bull; 1995 Aug; 21(2):64-72. PubMed ID: 8815864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased susceptibility of LDL to in vitro oxidation in patients with insulin-dependent and non-insulin-dependent diabetes mellitus.
    Cominacini L; Garbin U; Pastorino AM; Fratta Pasini A; Campagnola M; De Santis A; Davoli A; Lo Cascio V
    Diabetes Res; 1994; 26(4):173-84. PubMed ID: 7648791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum lipoprotein (a) concentrations in a population of 819 non-insulin-dependent diabetic patients.
    Durlach V; Gillery P; Bertin E; Taupin JM; Grulet H; Gross A; Leutenegger M
    Diabetes Metab; 1996 Oct; 22(5):319-23. PubMed ID: 8896993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of short-term modest weight loss on fasting and post-prandial lipoprotein sub-fractions in type 2 diabetes mellitus patients.
    Ybarra J; James RW; Makoundou V; Bioletto S; Golay A
    Diabetes Metab; 2001 Dec; 27(6):701-8. PubMed ID: 11852380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of glycaemic control and age on low-density lipoprotein susceptibility to oxidation in diabetes mellitus type 1.
    Liguori A; Abete P; Hayden JM; Cacciatore F; Rengo F; Ambrosio G; Bonaduce D; Condorelli M; Reaven PD; Napoli C
    Eur Heart J; 2001 Nov; 22(22):2075-84. PubMed ID: 11686665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble LDL-immune complexes in type 2 diabetes and vascular disease.
    Turk Z; Sesto M; Skodlar J; Ferencak G; Turk N; Stavljenić-Rukavina A
    Horm Metab Res; 2002 Apr; 34(4):196-201. PubMed ID: 11987029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of insulin treatment on plasma oxidized LDL/LDL-cholesterol ratio in type 2 diabetic patients.
    Galland F; Duvillard L; Petit JM; Lagrost L; Vaillant G; Brun JM; Gambert P; Vergès B
    Diabetes Metab; 2006 Dec; 32(6):625-31. PubMed ID: 17296517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein alterations in hemodialysis: differences between diabetic and nondiabetic patients.
    González AI; Schreier L; Elbert A; Berg G; Beresan H; López G; Wikinski R
    Metabolism; 2003 Jan; 52(1):116-21. PubMed ID: 12524671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LDL-cholesterol/apolipoprotein B ratio is a good predictor of LDL phenotype B in type 2 diabetes.
    Wägner AM; Jorba O; Rigla M; Alonso E; Ordóñez-Llanos J; Pérez A
    Acta Diabetol; 2002 Dec; 39(4):215-20. PubMed ID: 12486496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the body mass index and triglyceride levels in identifying insulin-sensitive and insulin-resistant variants in Japanese non-insulin-dependent diabetic patients.
    Taniguchi A; Fukushima M; Sakai M; Kataoka K; Nagata I; Doi K; Arakawa H; Nagasaka S; Tokuyama K; Nakai Y
    Metabolism; 2000 Aug; 49(8):1001-5. PubMed ID: 10954017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid levels and peripheral vascular disease in diabetic and non-diabetic subjects.
    O'Neal DN; Lewicki J; Ansari MZ; Matthews PG; Best JD
    Atherosclerosis; 1998 Jan; 136(1):1-8. PubMed ID: 9544725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atorvastatin affects low density lipoprotein and non-high density lipoprotein cholesterol relations with apolipoprotein B in type 2 diabetes mellitus: modification by triglycerides and cholesteryl ester transfer protein.
    Kappelle PJ; Zwang L; Huisman MV; Banga JD; Sluiter WJ; Dallinga-Thie GM; Dullaart RP
    Expert Opin Ther Targets; 2009 Jul; 13(7):743-51. PubMed ID: 19505224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative and qualitative derangement of apolipoprotein B-containing lipoproteins as a risk factor for diabetic macroangiopathy in nonobese NIDDM subjects.
    Harano Y; Kageyama A; Nakao Y; Hara Y; Suzuki M; Sato A; Ikebuchi M; Shinozaki K; Tsushima M
    Diabetes; 1996 Jul; 45 Suppl 3():S31-4. PubMed ID: 8674886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atherogenic lipoprotein phenotype and LDL size and subclasses in women with gestational diabetes.
    Rizzo M; Berneis K; Altinova AE; Toruner FB; Akturk M; Ayvaz G; Rini GB; Spinas GA; Arslan M
    Diabet Med; 2008 Dec; 25(12):1406-11. PubMed ID: 19046238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of apolipoprotein B and plasma lipids as targets for lipid lowering treatment.
    Vaverkova H; Frohlich J; Jackuliakova D; Novotny D
    Clin Biochem; 2005 Jun; 38(6):509-13. PubMed ID: 15885228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What is the best predictor of the atherogenic LDL subclass phenotype 'pattern B' in patients with type 2 diabetes mellitus?
    King RI; Florkowski CM; Yeo J; Walmsley TA; Shand BI; Scott RS; George PM
    Ann Clin Biochem; 2011 Mar; 48(Pt 2):166-9. PubMed ID: 21278248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma endothelin levels in NIDDM patients with macroangiopathy.
    Donatelli M; Colletti I; Bucalo ML; Russo V; Verga S
    Diabetes Res; 1994; 25(4):159-64. PubMed ID: 7648786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different levels of cardiovascular risk factors in type-2 diabetic patients with lower limb proximal and distal vessel macroangiopathy.
    Tkác I; Moscovic F; Molcányová A; Lazúr J; Takác M
    Cor Vasa; 1990; 32(4):311-9. PubMed ID: 2225880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase in thiobarbituric acid-reactive substances and vascular complications in type 2 diabetes mellitus.
    Gallou G; Ruelland A; Campion L; Maugendre D; Le Moullec N; Legras B; Allannic H; Cloarec L
    Diabete Metab; 1994; 20(3):258-64. PubMed ID: 8001713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.